CN103041255B - 治疗小儿咽喉肿痛呼吸道感染的中药制剂 - Google Patents
治疗小儿咽喉肿痛呼吸道感染的中药制剂 Download PDFInfo
- Publication number
- CN103041255B CN103041255B CN201210594265.XA CN201210594265A CN103041255B CN 103041255 B CN103041255 B CN 103041255B CN 201210594265 A CN201210594265 A CN 201210594265A CN 103041255 B CN103041255 B CN 103041255B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- herba
- respiratory tract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 57
- 206010057190 Respiratory tract infection Diseases 0.000 title claims abstract description 46
- 239000002398 materia medica Substances 0.000 title abstract description 5
- 206010068319 Oropharyngeal pain Diseases 0.000 title abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 120
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 241000931705 Cicada Species 0.000 claims abstract description 13
- 241000951473 Schizonepeta Species 0.000 claims abstract description 13
- 208000002193 Pain Diseases 0.000 claims description 31
- 230000036407 pain Effects 0.000 claims description 30
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 28
- 241000545442 Radix Species 0.000 claims description 25
- 241000628997 Flos Species 0.000 claims description 23
- 230000002522 swelling Effects 0.000 claims description 20
- 210000003026 Hypopharynx Anatomy 0.000 claims description 13
- 241000219780 Pueraria Species 0.000 claims description 13
- 241000395033 Kaempferia Species 0.000 claims description 12
- 235000013422 Kaempferia rotunda Nutrition 0.000 claims description 12
- 241001180876 Saposhnikovia Species 0.000 claims description 12
- 241000207929 Scutellaria Species 0.000 claims description 12
- 241000245240 Lonicera Species 0.000 claims description 10
- 201000010099 disease Diseases 0.000 abstract description 70
- 230000001717 pathogenic Effects 0.000 abstract description 37
- 229940079593 drugs Drugs 0.000 abstract description 30
- 239000000463 material Substances 0.000 abstract description 15
- 201000009910 diseases by infectious agent Diseases 0.000 abstract description 10
- 230000001754 anti-pyretic Effects 0.000 abstract description 9
- 231100000331 toxic Toxicity 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 8
- 230000003110 anti-inflammatory Effects 0.000 abstract description 6
- 239000002221 antipyretic Substances 0.000 abstract description 6
- 230000000840 anti-viral Effects 0.000 abstract description 5
- 231100000486 side effect Toxicity 0.000 abstract description 5
- 230000002708 enhancing Effects 0.000 abstract description 4
- 230000001932 seasonal Effects 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241000266855 Astragalus mongholicus Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000009242 dandelion Nutrition 0.000 abstract 1
- 235000014079 dandelion Nutrition 0.000 abstract 1
- 210000004072 Lung Anatomy 0.000 description 48
- 206010011224 Cough Diseases 0.000 description 47
- 210000000952 Spleen Anatomy 0.000 description 39
- 230000000694 effects Effects 0.000 description 36
- 210000004369 Blood Anatomy 0.000 description 25
- 239000008280 blood Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 206010037660 Pyrexia Diseases 0.000 description 23
- 239000009636 Huang Qi Substances 0.000 description 18
- 210000003734 Kidney Anatomy 0.000 description 17
- 210000002784 Stomach Anatomy 0.000 description 17
- 238000010438 heat treatment Methods 0.000 description 16
- 230000001737 promoting Effects 0.000 description 15
- 231100000614 Poison Toxicity 0.000 description 14
- 230000035922 thirst Effects 0.000 description 14
- 230000036760 body temperature Effects 0.000 description 13
- 235000013305 food Nutrition 0.000 description 13
- 206010019233 Headache Diseases 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 12
- 238000000605 extraction Methods 0.000 description 12
- 231100000869 headache Toxicity 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 210000000056 organs Anatomy 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 206010022000 Influenza Diseases 0.000 description 11
- 244000052769 pathogens Species 0.000 description 11
- 238000005728 strengthening Methods 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 210000003038 Endothelium Anatomy 0.000 description 10
- 208000003251 Pruritus Diseases 0.000 description 10
- 210000002700 Urine Anatomy 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 10
- 238000000108 ultra-filtration Methods 0.000 description 10
- 210000001124 Body Fluids Anatomy 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 206010047700 Vomiting Diseases 0.000 description 9
- 239000010231 banlangen Substances 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 238000010791 quenching Methods 0.000 description 9
- 230000001105 regulatory Effects 0.000 description 9
- 239000003440 toxic substance Substances 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 206010037844 Rash Diseases 0.000 description 8
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 8
- 230000000844 anti-bacterial Effects 0.000 description 8
- 206010061428 Decreased appetite Diseases 0.000 description 7
- 241000668709 Dipterocarpus costatus Species 0.000 description 7
- 208000008454 Hyperhidrosis Diseases 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 230000003203 everyday Effects 0.000 description 7
- 230000025627 positive regulation of urine volume Effects 0.000 description 7
- 201000005404 rubella Diseases 0.000 description 7
- 201000010874 syndrome Diseases 0.000 description 7
- 210000001015 Abdomen Anatomy 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 6
- 206010006451 Bronchitis Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 210000003128 Head Anatomy 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 6
- 206010021118 Hypotonia Diseases 0.000 description 6
- 210000000088 Lip Anatomy 0.000 description 6
- 210000000214 Mouth Anatomy 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 206010036790 Productive cough Diseases 0.000 description 6
- 210000004915 Pus Anatomy 0.000 description 6
- 210000003491 Skin Anatomy 0.000 description 6
- 208000004371 Toothache Diseases 0.000 description 6
- 230000001142 anti-diarrhea Effects 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 6
- 230000036528 appetite Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 235000019525 fullness Nutrition 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 239000002510 pyrogen Substances 0.000 description 6
- 230000002829 reduced Effects 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 230000035900 sweating Effects 0.000 description 6
- 230000001225 therapeutic Effects 0.000 description 6
- 208000010201 Exanthema Diseases 0.000 description 5
- 206010016286 Febrile disease Diseases 0.000 description 5
- 210000003800 Pharynx Anatomy 0.000 description 5
- 206010035664 Pneumonia Diseases 0.000 description 5
- 206010043458 Thirst Diseases 0.000 description 5
- 206010068760 Ulcers Diseases 0.000 description 5
- 230000003115 biocidal Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 201000005884 exanthem Diseases 0.000 description 5
- 230000003419 expectorant Effects 0.000 description 5
- 239000003172 expectorant agent Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 229910052602 gypsum Inorganic materials 0.000 description 5
- 239000010440 gypsum Substances 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 239000006187 pill Substances 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 235000019615 sensations Nutrition 0.000 description 5
- 230000002269 spontaneous Effects 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010003549 Asthenia Diseases 0.000 description 4
- 208000006673 Asthma Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 206010013781 Dry mouth Diseases 0.000 description 4
- 208000001848 Dysentery Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 210000002683 Foot Anatomy 0.000 description 4
- 210000002216 Heart Anatomy 0.000 description 4
- 206010020741 Hyperpyrexia Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 210000004185 Liver Anatomy 0.000 description 4
- 229940023488 Pill Drugs 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 206010072736 Rheumatic disease Diseases 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 210000004243 Sweat Anatomy 0.000 description 4
- 102000007501 Thymosin Human genes 0.000 description 4
- 108010046075 Thymosin Proteins 0.000 description 4
- 231100000765 Toxin Toxicity 0.000 description 4
- 210000000436 anus Anatomy 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 201000009230 common cold Diseases 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 201000005505 measles Diseases 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 101710031899 moon Proteins 0.000 description 4
- 201000009240 nasopharyngitis Diseases 0.000 description 4
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 4
- 230000001047 pyretic Effects 0.000 description 4
- 239000002965 rope Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 230000001954 sterilising Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000002588 toxic Effects 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 208000001780 Epistaxis Diseases 0.000 description 3
- 210000000232 Gallbladder Anatomy 0.000 description 3
- 206010062060 Hyperlipidaemia Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010022437 Insomnia Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 206010040872 Skin infection Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 241000223238 Trichophyton Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 208000005946 Xerostomia Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000001166 anti-perspirant Effects 0.000 description 3
- 239000003213 antiperspirant Substances 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 201000008286 diarrhea Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 201000000297 erysipelas Diseases 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000000968 intestinal Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002035 prolonged Effects 0.000 description 3
- 230000000171 quenching Effects 0.000 description 3
- 230000000306 recurrent Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 230000000552 rheumatic Effects 0.000 description 3
- 201000009890 sinusitis Diseases 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010000269 Abscess Diseases 0.000 description 2
- 241000605447 Anemarrhena Species 0.000 description 2
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 2
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 2
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 2
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 2
- 235000006793 Artemisia stelleriana Nutrition 0.000 description 2
- 240000008117 Artemisia stelleriana Species 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 210000000481 Breast Anatomy 0.000 description 2
- 208000008787 Cardiovascular Disease Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N Coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 208000002173 Dizziness Diseases 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N Gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 2
- 206010018836 Haematochezia Diseases 0.000 description 2
- 206010018987 Haemorrhage Diseases 0.000 description 2
- 210000001624 Hip Anatomy 0.000 description 2
- 208000006572 Human Influenza Diseases 0.000 description 2
- 210000000936 Intestines Anatomy 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N Kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 208000009856 Lung Disease Diseases 0.000 description 2
- 208000004396 Mastitis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N Methyl eugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 210000003205 Muscles Anatomy 0.000 description 2
- 206010028836 Neck pain Diseases 0.000 description 2
- 210000002741 Palatine Tonsil Anatomy 0.000 description 2
- 208000008425 Protein Deficiency Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 208000008128 Pulmonary Tuberculosis Diseases 0.000 description 2
- 210000003324 RBC Anatomy 0.000 description 2
- 206010038683 Respiratory disease Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 102100012531 SLC25A13 Human genes 0.000 description 2
- 210000000582 Semen Anatomy 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 2
- 206010044302 Tracheitis Diseases 0.000 description 2
- 210000003932 Urinary Bladder Anatomy 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 208000001877 Whooping Cough Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 230000002547 anomalous Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000001174 ascending Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000003542 behavioural Effects 0.000 description 2
- 231100000319 bleeding Toxicity 0.000 description 2
- 230000000740 bleeding Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000004579 body weight change Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000001914 calming Effects 0.000 description 2
- 201000001084 cerebrovascular disease Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 108010084210 citrin Proteins 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 235000006413 coastal sagewort Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000029578 entry into host Effects 0.000 description 2
- 230000001605 fetal Effects 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 239000010135 fructus aurantii immaturus Substances 0.000 description 2
- 108010074605 gamma-Globulins Proteins 0.000 description 2
- 230000002496 gastric Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000002489 hematologic Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000001861 immunosuppresant Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 238000009169 immunotherapy Methods 0.000 description 2
- 229940079866 intestinal antibiotics Drugs 0.000 description 2
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 2
- 229930013032 isoflavonoids Natural products 0.000 description 2
- 235000012891 isoflavonoids Nutrition 0.000 description 2
- 230000002045 lasting Effects 0.000 description 2
- 230000003211 malignant Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000004914 menses Anatomy 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000000414 obstructive Effects 0.000 description 2
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 2
- 244000045947 parasites Species 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 201000005702 pertussis Diseases 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 210000001995 reticulocyte Anatomy 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 238000002636 symptomatic treatment Methods 0.000 description 2
- 230000002936 tranquilizing Effects 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3β-hydroxy-Olean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 210000003165 Abomasum Anatomy 0.000 description 1
- 229960004373 Acetylcholine Drugs 0.000 description 1
- 208000004631 Alopecia Areata Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010002156 Anal fistula Diseases 0.000 description 1
- 206010003119 Arrhythmia Diseases 0.000 description 1
- 208000002894 Beriberi Diseases 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010007521 Cardiac arrhythmias Diseases 0.000 description 1
- 230000036536 Cave Effects 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 210000003467 Cheek Anatomy 0.000 description 1
- 229940107161 Cholesterol Drugs 0.000 description 1
- 229960001231 Choline Drugs 0.000 description 1
- 208000007451 Chronic Bronchitis Diseases 0.000 description 1
- 229940121657 Clinical Drug Drugs 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 208000004981 Coronary Disease Diseases 0.000 description 1
- 210000004351 Coronary Vessels Anatomy 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000000264 Deglutition Disorders Diseases 0.000 description 1
- 206010013023 Diphtheria Diseases 0.000 description 1
- 206010013950 Dysphagia Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013990 Dysuria Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015037 Epilepsy Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 210000003414 Extremities Anatomy 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- 229940074391 Gallic acid Drugs 0.000 description 1
- 210000004051 Gastric Juice Anatomy 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 210000001035 Gastrointestinal Tract Anatomy 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 229940088597 Hormone Drugs 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N Inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 Inulin Drugs 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000731961 Juncaceae Species 0.000 description 1
- PUPKKEQDLNREIM-VKUWDBPGSA-N Kaempferitrin Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1)c1cc(O)c2C(=O)C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)=C(c3ccc(O)cc3)Oc2c1 PUPKKEQDLNREIM-VKUWDBPGSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010025482 Malaise Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N Malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 206010027327 Menstrual disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 210000003097 Mucus Anatomy 0.000 description 1
- 206010028334 Muscle spasms Diseases 0.000 description 1
- 210000002464 Muscle, Smooth, Vascular Anatomy 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 229940013390 Mycoplasma pneumoniae Drugs 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010058117 Ocular icterus Diseases 0.000 description 1
- 229940100243 Oleanolic Acid Drugs 0.000 description 1
- MIJYXULNPSFWEK-LXLHWSNGSA-N Oleanolic acid Natural products C1C[C@H](O)C(C)(C)[C@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@@H]5C4=CC[C@H]3[C@]21C MIJYXULNPSFWEK-LXLHWSNGSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 206010067781 Pharyngeal abscess Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000003801 Retropharyngeal Abscess Diseases 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 206010040943 Skin ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 210000003802 Sputum Anatomy 0.000 description 1
- 206010042772 Syncope Diseases 0.000 description 1
- 210000000662 T-Lymphocyte Subsets Anatomy 0.000 description 1
- VXMKYRQZQXVKGB-CWWHNZPOSA-N Tannin Chemical compound O([C@H]1[C@H]([C@@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)O[C@H]([C@H]2O)O1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 VXMKYRQZQXVKGB-CWWHNZPOSA-N 0.000 description 1
- 210000001138 Tears Anatomy 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 210000003437 Trachea Anatomy 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 210000001215 Vagina Anatomy 0.000 description 1
- 206010052769 Vertigos Diseases 0.000 description 1
- 206010047461 Viral infection Diseases 0.000 description 1
- 206010047470 Viral myocarditis Diseases 0.000 description 1
- 208000001756 Virus Disease Diseases 0.000 description 1
- 229940088594 Vitamin Drugs 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 230000001004 anti-acetylcholinic Effects 0.000 description 1
- 230000002605 anti-dotal Effects 0.000 description 1
- 230000000410 anti-febrile Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- 201000001320 atherosclerosis Diseases 0.000 description 1
- 244000052616 bacterial pathogens Species 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000001413 cellular Effects 0.000 description 1
- 201000009058 cervical adenitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- CRBHXDCYXIISFC-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CC[O-] CRBHXDCYXIISFC-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 201000008739 coronary artery disease Diseases 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000001079 digestive Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 239000003721 gunpowder Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000008929 jingui shenqi Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- PUPKKEQDLNREIM-QNSQPKOQSA-N kaempferol 3-O-α-L-rhamnopyranosyl-7-O-α-L-rhamnopyranoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=CC(O)=C2C(=O)C(O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=C(C=3C=CC(O)=CC=3)OC2=C1 PUPKKEQDLNREIM-QNSQPKOQSA-N 0.000 description 1
- 230000002147 killing Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000002879 macerating Effects 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000002107 myocardial Effects 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000001473 noxious Effects 0.000 description 1
- 230000000050 nutritive Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001314 paroxysmal Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-M quercitrin-7-olate Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC([O-])=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-M 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing Effects 0.000 description 1
- 230000001846 repelling Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000035812 respiration Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000003248 secreting Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000017613 viral reproduction Effects 0.000 description 1
- 230000003612 virological Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Abstract
Description
免疫指标 | 治疗前 | 治疗后 |
IgG(g/L) | 6.12±0.14 | 7.89±0.19 |
IgA(g/L) | 5.16±0.46 | 9.87±0.26 |
IgM(g/L) | 0.97±0.14 | 1.23±0.27 |
CD3+(%) | 40.1±1.7 | 56.9±1.6 |
CD4+(%) | 24.4±1.6 | 33.7±1.8 |
CD8+(%) | 20.4±1.9 | 24.6±1.2 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210594265.XA CN103041255B (zh) | 2012-12-31 | 2012-12-31 | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210594265.XA CN103041255B (zh) | 2012-12-31 | 2012-12-31 | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103041255A CN103041255A (zh) | 2013-04-17 |
CN103041255B true CN103041255B (zh) | 2014-06-18 |
Family
ID=48054266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210594265.XA Expired - Fee Related CN103041255B (zh) | 2012-12-31 | 2012-12-31 | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103041255B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104740443A (zh) * | 2015-04-07 | 2015-07-01 | 范永启 | 一种中药复方精油 |
CN104888123A (zh) * | 2015-06-15 | 2015-09-09 | 韦洪伟 | 一种用于小儿呼吸道感染的制剂及其制备和检测方法 |
CN106890277A (zh) * | 2017-04-16 | 2017-06-27 | 阎玉珍 | 一种小儿百日咳期久咳伴有肺炎的清肺化痰中药制剂及其制备方法 |
-
2012
- 2012-12-31 CN CN201210594265.XA patent/CN103041255B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103041255A (zh) | 2013-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048933B (zh) | 一种治疗小儿腹泻的中药组合物及其制备方法 | |
CN101972338B (zh) | 一种治疗小儿上呼吸道感染的中药制剂及其制备方法 | |
CN103169903B (zh) | 一种治疗小儿支气管炎的中药制剂及其制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103099959B (zh) | 一种治疗溃疡性结肠炎的中药制剂及其制备方法 | |
CN102772781A (zh) | 一种治疗慢性结肠炎的中药制剂及其制备方法 | |
CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
CN103301267A (zh) | 一种治疗高血压和/或动脉粥样硬化的中药组合物及应用 | |
CN105311581A (zh) | 一种预防和治疗乳腺增生的中药组合物及其制备方法 | |
CN103041262B (zh) | 一种治疗慢性前列腺炎的中药灌肠剂及其制备方法 | |
CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
CN105497816A (zh) | 一种治疗动脉粥样硬化的中药制剂及其制备方法 | |
CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN106267028A (zh) | 一种治疗肺炎的中药组合物及其制备方法 | |
CN103041258B (zh) | 治疗小儿呼吸道感染伴纳差不食的中药制剂 | |
CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
CN105056078A (zh) | 一种治疗胃火炽盛牙痛口臭的中药组合物 | |
CN104887950A (zh) | 一种治疗乳痈的中药组合物 | |
CN103877484A (zh) | 一种治疗慢性肠炎的中药口服液 | |
CN104206597B (zh) | 一种缓解肺肾阴虚症状的五味子保健茶及其制备方法 | |
CN103041259B (zh) | 治疗小儿痰多咳嗽呼吸道感染的中药制剂 | |
CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
CN107260849A (zh) | 一种治疗风热感冒的中药口服液及其生产方法 | |
CN107468920A (zh) | 一种治疗输血溶血反应的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: WU YINGTAO Free format text: FORMER OWNER: QINGDAO HUAREN INFORMATION TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20140516 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wu Yingtao Inventor after: Wang Wanchun Inventor after: Li Shijie Inventor after: Zhang Wenyi Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: WU YINGTAO WANG WANCHUN LI SHIJIE ZHANG WENYI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140516 Address after: 266071 Shandong Province, Qingdao city Taizhou Road No. 2 304 Applicant after: Wu Yingtao Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 (Minmetals building) 11 1101-A Applicant before: Qingdao Huaren Information Technology Development Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140618 Termination date: 20201231 |
|
CF01 | Termination of patent right due to non-payment of annual fee |